Clinical trial
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With…
NCT00003929 · Case Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00003929 |
|---|---|
| Title | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
| Official title | Combined Modality Therapy of AIDS-Related and Immunocompetent Primary CNS Lymphoma (PCL) Using Filgrastim (G-CSF) |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, lomustine, procarbazine hydrochloride, radiation therapy |
| Enrollment | 0 |
| Start date | Jun 1, 1998 |
| Primary completion | Mar 1, 2000 |
| First posted | Jul 26, 2004 |
| Last update posted | Mar 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: